It is with pleasure we announce Karyo's collaboration with MDxHealth in Southern Greece!
MDxHealth is a multinational healthcare company that provides actionable epigenetic information to personalize the diagnosis and treatment of cancer. The increased adoption of our ConfirmMDx® for Prostate Cancer testing solution within the U.S. urology community has established MDxHealth as a market leader in the important and growing field of cancer epigenetics.
Genetic testing for hereditary cancer: High quality, affordable to all!
Karyo announces the arrival of Color in our region! Color is a 30 gene panel, including BRCA1 and BRCA2, to assist women and men understand their risk for the most common hereditary cancers, including breast, ovarian, colorectal, and pancreatic cancer. and others. Color revolutionizes genetic testing with a series of characteristics:
Με χαρά σας ανακοινώνουμε τη συμμετοχή μας στο 3ο Πανελλήνιο Συνέδριο ‘Ενωσης Μαιευτήρων Γυναικολόγων Ελλάδος με τη διοργάνωση δορυφορικού συμποσίου με θέμα τον Μη Επεμβατικό Προγεννητικό Έλεγχο (ΝΙΡΤ).